Anmol India Share Price Target

Anmol India Share Price Target Tomorrow 2024 To 2030 – Stock Market Update

Anmol India Ltd is a growing company primarily involved in the trading of coal and other energy products. It caters to various industries, including textiles, chemicals, and bricks, by providing high-quality coal to meet their energy needs. The company is known for its efficient supply chain and strong relationships with domestic and international suppliers. Anmol…

Zeal Aqua Share Price Target

Zeal Aqua Share Price Target Tomorrow 2024 To 2030- Prediction, Market Overview

Zeal Aqua Ltd is a company engaged in the aquaculture industry, primarily focusing on shrimp farming and related activities. Based in Gujarat, India, the company is dedicated to producing high-quality shrimp to meet growing domestic and international demand. Zeal Aqua emphasizes sustainable farming practices, ensuring environmental balance while maintaining high production standards. Zeal Aqua Share…

Luxury Stocks Find China Solace to End Bad Year on Brighter Note: Know More Here

Luxury Stocks Find China Solace to End Bad Year on Brighter Note: Know More Here

Investors feel less pain following a year marked by worries about declining demand in China, the world’s largest market, thanks to a December comeback in European luxury goods stocks. With multiple rounds of stimulus in China aimed at revitalizing the world’s second-largest economy, optimism is returning, putting shares of luxury goods manufacturers on track for…

Indrayani Biotech Share Price Target

Indrayani Biotech Share Price Target Tomorrow 2024 To 2030- Market Overview, Financials

Indrayani Biotech Ltd is a dynamic company operating in the biotechnology and agro-based industries. It focuses on innovative solutions in food processing, bio-based products, and agricultural advancements. Known for its customer-centric approach, the company works towards creating sustainable and high-quality offerings. Indrayani Biotech Share Price on BOM as of 18 December 2024 is 36.60 INR….

Mankind Pharma shares in focus after co launches Rs 3,000 crore QIP

Mankind Pharma shares in focus after co launches Rs 3,000 crore QIP

Mankind Pharma’s stock increased 2.3% during trading, reaching an intraday high of Rs 2,753 on the BSE. A day after the company’s qualified institutional placement (QIP) was launched, the stock was purchased at a floor price of Rs 2,616.55 per share. This is a 2.4% reduction from the closing price on Monday. According to its…

Brahmaputra Infrastructure Ltd Share Price Target

Brahmaputra Infrastructure Ltd Share Price Target Tomorrow 2024 To 2030

Brahmaputra Infrastructure Ltd. is a prominent company engaged in infrastructure development and construction projects across India. The company specializes in executing large-scale projects in sectors such as roads, highways, bridges, and other civil construction works. Brahmaputra Infrastructure Ltd Share Price on BOM as of 18 December 2024 is 55.40 INR. Here are more details on Brahmaputra…

JPMorgan’s Head of Currency Trading Sees Trump Boosting Volumes

JPMorgan’s Head of Currency Trading Sees Trump Boosting Volumes

JPMorgan Chase & Co. claims that Donald Trump’s entry to the White House is driving up currency trading volumes because of his trade policies, which are drawing more attention to foreign exchange markets. Head of currencies and emerging markets trading at the US bank Stephen Jefferies said he expects a busy year ahead and that…

Hindustan Copper, National Aluminium among 6 stocks in F&O ban list today

Hindustan Copper, National Aluminium among 6 stocks in F&O ban list today

On Tuesday, December 17, trading in six equities in the futures and options (F&O) segment was prohibited by the National Stock Exchange (NSE) because they had over 95% of the market-wide position limit (MWPL). These equities will, nevertheless, be traded on the cash market. The list of securities in the F&O ban for trade is…

Lupin shares in focus on acquisition of 3 anti-diabetes trademarks to strengthen diabetes portfolio

Lupin shares in focus on acquisition of 3 anti-diabetes trademarks to strengthen diabetes portfolio

Global pharmaceutical giant Lupin Limited said Friday that it has strengthened its diabetes portfolio in India by acquiring the anti-diabetic trademarks GIBTULIO, GIBTULIO MET, and AJADUO from Boehringer Ingelheim International GmbH (Boehringer Ingelheim). According to the agreement, Lupin will receive the trademark rights for these brands by March of the following year. In the Indian…

ONGC shares drop after co issues clarification on green energy arm’s listing plans

ONGC shares drop after co issues clarification on green energy arm’s listing plans

On Monday, ONGC shares started slightly down at Rs 253.35 after the company made it clear that it currently has no firm plans to list its affiliate, ONGC Green, on the stock exchange. “ONGC would like to clarify regarding the news article on the likely public listing of ONGC Green Limited (OGL). The question was…